London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
There doesn’t appear to have been an RNS here about the proposed name change to Argent BioPharma, as reported in businessofcannabis.com .
I dumped shares in this outfit a couple of years ago when I realised that information about it was very scant and unconvincing.
The website is superficial (check out the 'about us' section) with stock photos and no substantive detail about corporate addresses in UK, Australia, Malta, or elsewhere for that matter. No key qualified research staff are mentioned- it’s even less convincing than it was when I last checked it out and has all the features of a well presented scam. If the company is genuine then it's not surprising that it is failing.
Have a read at this it tells you about the name change, and lots of other info.
https://www.investi.com.au/api/announcements/mxc/26603a17-de0.pdf
It's dead jim...
Ha! No kidding Darth?
But this is a prominent European pharmaceutical company isn't it?
The website contains very pretty family snaps but surprisingly does not include any of the 'new, large scale production facilities' in Malta or give contact details for sales, enquiries or its corporate HQ , which it says is in the UK - but isn't it in Australia (very prominent on the map) ?.
How many employees are there and what key research, sales and production activities are being undertaken?
After all, according to the website, MGC Pharma has built strong relationships to produce the most rigorous research and develop a high-quality clinical pipeline with the most qualified, passionate experts in the pharmaceutical industry....
Lots of superlatives but no names, quotes or details.
It's hard to believe it exists based on the lack of substance there. Speaking of which, I must have another drag.
Kalhussain: I guess a proposed name change is not significant enough to notify shareholders by RNS .
Lol mgc has to be a shop front for something else :).
As shopfronts go, Darth, it's not very well lit.
From latest GM Documents: 'The Board proposes this change of name [to Argent Biopharma] on the basis that it believes the proposed name more accurately reflects the future operations of the Company.'
The term Biopharma might be slightly more precise. However, the name Argent provides a very useful separation from the somewhat obscure MGC and its dismal performance since it was listed in the UK. Could that be a more likely reason for the name change?
Meanwhile, looking at the Malta premises on Google (it's marked in the Hal Far Industrial Estate, Birżebbuġa) I expected to see a large glasshouse on the roof (as per drawings in the Edison Report dated 10/7/2019 on the MGC website) but the satellite image appears to pre-date the installation. The site has a five star rating on Google by a chap who gives no reason, no photo and possibly clicked on it by mistake whilst adding other places in the area. You'd think this stunning facility, funded by shareholders, would be a star feature on the MGC website wouldn't you?
So many questions....